Cargando…
Primary Diffuse Large B-Cell Lymphoma of the Urinary Bladder: Update on a Rare Disease and Potential Diagnostic Pitfalls
Diffuse large B-cell lymphoma (DLBCL) represents the most frequent type of non-Hodgkin lymphoma. Globally, DLBCL is an aggressive disease, requiring an accurate diagnosis and prompt treatment. The diagnosis is often made on biopsy samples of a nodal mass, however, approximately 40% of DLBCL cases ar...
Autores principales: | Zanelli, Magda, Sanguedolce, Francesca, Zizzo, Maurizio, Palicelli, Andrea, Pellegrini, David, Farinacci, Sabrina, Soriano, Alessandra, Froio, Elisabetta, Cormio, Luigi, Carrieri, Giuseppe, Cavazza, Alberto, Merli, Francesco, Pileri, Stefano A., Ascani, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870454/ https://www.ncbi.nlm.nih.gov/pubmed/35200580 http://dx.doi.org/10.3390/curroncol29020081 |
Ejemplares similares
-
Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer
por: Sanguedolce, Francesca, et al.
Publicado: (2023) -
HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic, and Predictive Role
por: Sanguedolce, Francesca, et al.
Publicado: (2023) -
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression
por: Sanguedolce, Francesca, et al.
Publicado: (2022) -
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)
por: Zanelli, Magda, et al.
Publicado: (2021) -
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation
por: Sanguedolce, Francesca, et al.
Publicado: (2022)